-
Microarray analysis of gene expression during epithelial-mesenchymal transformation.
Dev Dyn. 2005 Sep;234(1):132-42
PMID: 16010672
-
Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease.
J Clin Invest. 2009 Jun;119(6):1438-49
PMID: 19487820
-
Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: tumor budding as oncotarget.
Oncotarget. 2010 Nov;1(7):651-61
PMID: 21317460
-
Identification of genes whose expression is associated with cisplatin resistance in human ovarian carcinoma cells.
Cancer Chemother Pharmacol. 2006 Sep;58(3):384-95
PMID: 16404635
-
Genetics of kidney development.
Curr Opin Nephrol Hypertens. 1996 May;5(3):282-7
PMID: 8737865
-
Pharmacogenomics of taxane/platinum therapy in ovarian cancer.
Int J Gynecol Cancer. 2009 Dec;19 Suppl 2:S30-4
PMID: 19955911
-
Analyzing real-time PCR data by the comparative C(T) method.
Nat Protoc. 2008;3(6):1101-8
PMID: 18546601
-
Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer.
Cancer Metastasis Rev. 2009 Dec;28(3-4):335-44
PMID: 20012924
-
Cancer early dissemination: cancerous epithelial-mesenchymal transdifferentiation and transforming growth factor β signalling.
J Biochem. 2011 Jun;149(6):633-9
PMID: 21478191
-
Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.
PLoS Med. 2008 Dec 2;5(12):e232
PMID: 19053170
-
Drug transporters of platinum-based anticancer agents and their clinical significance.
Drug Resist Updat. 2011 Feb;14(1):22-34
PMID: 21251871
-
An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.
J Clin Oncol. 2007 Feb 10;25(5):517-25
PMID: 17290060
-
The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer.
Gynecol Oncol. 2010 Feb;116(2):282-5
PMID: 19931138
-
Pathway analysis of gene lists associated with platinum-based chemotherapy resistance in ovarian cancer: the big picture.
Gynecol Oncol. 2010 May;117(2):170-6
PMID: 20132968
-
Metastasis mechanisms.
Biochim Biophys Acta. 2009 Dec;1796(2):293-308
PMID: 19683560
-
The basics of epithelial-mesenchymal transition.
J Clin Invest. 2009 Jun;119(6):1420-8
PMID: 19487818
-
Snail blocks the cell cycle and confers resistance to cell death.
Genes Dev. 2004 May 15;18(10):1131-43
PMID: 15155580
-
Twist function is required for the morphogenesis of the cephalic neural tube and the differentiation of the cranial neural crest cells in the mouse embryo.
Dev Biol. 2002 Jul 15;247(2):251-70
PMID: 12086465
-
Drug resistant MCF-7 cells exhibit epithelial-mesenchymal transition gene expression pattern.
Biomed Pharmacother. 2011 Feb;65(1):40-5
PMID: 21177063
-
Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression.
Cancer Sci. 2007 Oct;98(10):1512-20
PMID: 17645776
-
Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer.
Cancer Res. 2009 Jul 15;69(14):5820-8
PMID: 19584296
-
Transcription factors that mediate epithelial-mesenchymal transition lead to multidrug resistance by upregulating ABC transporters.
Cell Death Dis. 2011 Jul 07;2:e179
PMID: 21734725
-
Gene-expression profiling in epithelial ovarian cancer.
Nat Clin Pract Oncol. 2008 Oct;5(10):577-87
PMID: 18648354
-
Biomarkers for epithelial-mesenchymal transitions.
J Clin Invest. 2009 Jun;119(6):1429-37
PMID: 19487819
-
Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.
Dev Cell. 2008 Jun;14(6):818-29
PMID: 18539112
-
Epithelial-mesenchymal transition in cancer development and its clinical significance.
Cancer Sci. 2010 Feb;101(2):293-9
PMID: 19961486
-
Promotion of tumor cell metastasis and vasculogenic mimicry by way of transcription coactivation by Bcl-2 and Twist1: a study of hepatocellular carcinoma.
Hepatology. 2011 Nov;54(5):1690-706
PMID: 21748764
-
The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs.
Crit Rev Immunol. 2009;29(3):241-54
PMID: 19538137
-
Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer.
Nat Rev Cancer. 2010 May;10(5):371-8
PMID: 20383179
-
Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
J Cell Mol Med. 2011 Mar;15(3):691-700
PMID: 20219012
-
Structural studies of interactions between anticancer platinum drugs and DNA.
Prog Biophys Mol Biol. 1996;66(1):81-111
PMID: 9107133
-
Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780.
Cancer Lett. 2011 Oct 1;309(1):11-8
PMID: 21676537
-
Diagnostic markers for early detection of ovarian cancer.
Clin Cancer Res. 2008 Feb 15;14(4):1065-72
PMID: 18258665
-
Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling.
Lab Invest. 2011 Mar;91(3):426-38
PMID: 21283078
-
Platinum-DNA interactions and subsequent cellular processes controlling sensitivity to anticancer platinum complexes.
Chem Biodivers. 2010 Mar;7(3):543-66
PMID: 20232326
-
Chemotherapy: Current drugs still have potential in advanced ovarian cancer.
Nat Rev Clin Oncol. 2010 Apr;7(4):191-3
PMID: 20354543
-
Gene expression response to cisplatin treatment in drug-sensitive and drug-resistant ovarian cancer cells.
Oncogene. 2007 May 3;26(20):2860-72
PMID: 17072341
-
Slug confers resistance to the epidermal growth factor receptor tyrosine kinase inhibitor.
Am J Respir Crit Care Med. 2011 Apr 15;183(8):1071-9
PMID: 21037017
-
Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells.
Stem Cells. 2009 Sep;27(9):2059-68
PMID: 19544473
-
Molecular mechanisms of cisplatin resistance.
Oncogene. 2012 Apr 12;31(15):1869-83
PMID: 21892204
-
Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression.
J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):117-34
PMID: 20490631
-
Current clinical use of biomarkers for epithelial ovarian cancer.
Curr Opin Oncol. 2010 Sep;22(5):492-7
PMID: 20613519
-
EMT: when epithelial cells decide to become mesenchymal-like cells.
J Clin Invest. 2009 Jun;119(6):1417-9
PMID: 19487817
-
Intraperitoneal cisplatin-based chemotherapy vs. intravenous cisplatin-based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancer.
Int J Gynaecol Obstet. 2001 Jan;72(1):55-60
PMID: 11146078
-
Ovarian cancer: epidemiology, biology, and prognostic factors.
Semin Surg Oncol. 2000 Jul-Aug;19(1):3-10
PMID: 10883018
-
The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it.
Dev Dyn. 2005 Jul;233(3):706-20
PMID: 15937929